SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 4.651
AS - Asia 2.762
EU - Europa 2.339
SA - Sud America 476
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 10.317
Nazione #
US - Stati Uniti d'America 4.393
SG - Singapore 957
IT - Italia 511
CN - Cina 487
VN - Vietnam 437
HK - Hong Kong 385
BR - Brasile 358
DE - Germania 355
RU - Federazione Russa 335
SE - Svezia 281
CA - Canada 210
IE - Irlanda 205
FR - Francia 159
GB - Regno Unito 142
IN - India 100
UA - Ucraina 68
ID - Indonesia 51
BD - Bangladesh 50
IQ - Iraq 48
AT - Austria 47
TR - Turchia 43
FI - Finlandia 42
AR - Argentina 36
NL - Olanda 33
JP - Giappone 32
DK - Danimarca 30
MX - Messico 30
ES - Italia 28
PL - Polonia 28
CO - Colombia 26
ZA - Sudafrica 26
PK - Pakistan 22
KR - Corea 19
SA - Arabia Saudita 19
PH - Filippine 17
EC - Ecuador 16
BE - Belgio 13
UZ - Uzbekistan 12
KE - Kenya 11
VE - Venezuela 11
CL - Cile 10
AE - Emirati Arabi Uniti 9
CH - Svizzera 9
IR - Iran 9
MY - Malesia 9
CZ - Repubblica Ceca 8
LT - Lituania 8
OM - Oman 8
DZ - Algeria 7
MA - Marocco 7
BG - Bulgaria 6
GR - Grecia 6
PE - Perù 6
PY - Paraguay 6
SN - Senegal 6
EG - Egitto 5
IL - Israele 5
JO - Giordania 5
AU - Australia 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
SY - Repubblica araba siriana 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GE - Georgia 2
KG - Kirghizistan 2
LY - Libia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EE - Estonia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MN - Mongolia 1
Totale 10.305
Città #
Ann Arbor 894
Singapore 543
Ashburn 386
Hong Kong 375
San Jose 291
Frankfurt am Main 257
Chandler 244
Fairfield 225
Dublin 200
New York 170
Wilmington 150
Toronto 149
Ho Chi Minh City 121
Hanoi 116
Houston 115
Woodbridge 111
Los Angeles 105
Milan 105
Beijing 92
Seattle 89
Chicago 87
Paris 83
Santa Clara 82
Dallas 81
Cambridge 70
Princeton 70
The Dalles 50
Jacksonville 49
Hefei 46
Jakarta 43
Buffalo 39
Lauterbourg 38
Altamura 37
Dearborn 36
Council Bluffs 35
Vienna 34
Moscow 33
São Paulo 33
Lawrence 32
Shanghai 31
London 26
Tokyo 26
Pune 23
Rome 23
Guangzhou 22
Baghdad 21
Haiphong 21
Orem 21
Johannesburg 20
Nanjing 20
Warsaw 20
Denver 19
Montreal 19
Nuremberg 19
Seoul 19
Poplar 18
Andover 17
Boardman 17
Fremont 17
Helsinki 17
Stockholm 17
Bogotá 15
Boston 15
Munich 15
Amsterdam 14
Brooklyn 14
Dong Ket 14
Phoenix 14
Lappeenranta 13
Ottawa 13
San Diego 13
Bologna 12
Brussels 12
Da Nang 11
Nairobi 11
Rio de Janeiro 11
Salt Lake City 11
Tashkent 11
Changsha 10
Manchester 10
Thái Nguyên 10
Atlanta 9
Chennai 9
Hangzhou 9
Hải Dương 9
Jeddah 9
Lachine 9
Quận Bình Thạnh 9
Biên Hòa 8
Catania 8
Columbus 8
Falls Church 8
Mexico City 8
Shenyang 8
Barnet 7
Busto Arsizio 7
Dhaka 7
Guarulhos 7
Hebei 7
Kent 7
Totale 6.571
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 518
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 391
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 364
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 348
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 322
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 320
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 319
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 316
HIV testing: A must for patients with inflammatory bowel disease 311
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 305
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 305
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 301
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 298
High rates of 30-day mortality in patients with cirrhosis and COVID-19 297
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 292
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 271
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 261
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 257
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 254
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 244
Unmasking tuberculosis in the era of antiretroviral treatment 243
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 239
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 236
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 232
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 231
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 220
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 211
Beware of biases in observational studies on anti-spike monoclonal antibodies 208
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 205
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 204
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 202
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis Service 200
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 184
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 173
Imported ciprofloxacin-resistant Neisseria meningitidis 166
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 165
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 163
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 153
Pharmacotherapy of HIV: Focus on Etravirine 139
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 112
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 107
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 98
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study 84
Reply 63
Reply 61
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 10.596
Categoria #
all - tutte 34.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021181 0 0 0 0 0 0 0 0 0 0 63 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.995 84 189 128 79 155 92 141 66 154 258 140 509
2025/20264.019 503 204 318 498 545 226 647 171 292 386 229 0
Totale 10.596